FULGENT THERAPEUTICS
Fulgent Therapeutics was issued its CLIA license (CLIA 05D2043189/CLF 00342581). Apart from traditional single gene tests, Fulgent Therapeutics has been investing heavily in the future. Using Next Generation Sequencing (NGS) technology we are developing a new series of panel based tests for our clients.
FULGENT THERAPEUTICS
Industry:
Biotechnology Genetics Pharmaceutical Therapeutics
Founded:
2011-01-01
Address:
Temple City, California, United States
Country:
United States
Website Url:
http://www.fulgentgenetics.com
Total Employee:
11+
Status:
Active
Contact:
626-350-0537
Email Addresses:
[email protected]
Total Funding:
34.83 M USD
Technology used in webpage:
SPF Global Site Tag Amazon Google Apps For Business Microsoft Azure DNS US Privacy User Signal Mechanism Amazon Route 53 Amazon Oregon Region KnowBe4
Similar Organizations
Baudax Bio
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
NewBridge Pharmaceuticals
Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.
Ocumension Therapeutics
Ocumension Therapeutics is a pharmaceutical platform dedicated to identifying, developing, and commercializing ophthalmic therapies.
Raptor Pharmaceuticals
Raptor is a NASDAQ-listed biopharmaceutical company with the mission to develop and commercialize life-altering therapeutics.
Rhythm Pharmaceuticals
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Santi Therapeutics
Santi Therapeutics is a pharmaceutical company that focuses on the research and development of small molecule therapeutics.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-08-09 | CSI Laboratories | CSI Laboratories acquired by Fulgent Therapeutics | N/A |
| 2021-05-10 | FF Gene Biotech | FF Gene Biotech acquired by Fulgent Therapeutics | 19 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-23 | Spatial Genomics | Fulgent Therapeutics investment in Series A - Spatial Genomics | 56 M USD |
Official Site Inspections
http://www.fulgentgenetics.com Semrush global rank: 141.81 K Semrush visits lastest month: 619.02 K
- Host name: ec2-35-85-101-18.us-west-2.compute.amazonaws.com
- IP address: 35.85.101.18
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
